2019 MIPS Measure #066: Appropriate Testing for Children with Pharyngitis

Measure Type High Priority Measure? Collection Type(s)
Process yes eCQM, MIPS CQM

Measure Description

Percentage of children 3-18 years of age who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episode

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.


Instructions

This measure is to be submitted once for each occurrence of pharyngitis during the performance period. Claims data will be analyzed to determine unique occurrences. This measure is intended to reflect the quality of services provided for the primary management of patients with pharyngitis who were dispensed an antibiotic. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Measure Submission Type:

Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.

Denominator

Children 3 – 18 years of age who had an outpatient or emergency department (ED) visit with a diagnosis of pharyngitis during the measurement period and an antibiotic ordered on or three days after the visit

Denominator Instructions:

To determine eligibility, look for any of the listed antibiotic drugs below in the 30 days prior to the visit with the pharyngitis diagnosis. As long as there are no prescriptions for the listed antibiotics during this time period, the patient is eligible for denominator inclusion.

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.

Denominator Criteria (Eligible Cases): Patients aged 3 to 18 years on date of encounter

AND

Diagnosis for pharyngitis (ICD-10-CM): J02.0, J02.8, J02.9, J03.00, J03.01, J03.80, J03.81, J03.90, J03.91

AND

Patient encounter during the performance period (CPT or HCPCS): 96160, 96161, 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99217, 99218, 99219, 99220, 99241*, 99242*, 99243*, 99244*, 99245*, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99401*, 99402*, 99403*, 99404*, 99411*, 99412*, 99429*, 99455, 99456, 99281, 99282, 99283, 99284, 99285, G0402

AND

Prescribed or dispensed antibiotic: G8711

AND NOT

DENOMINATOR EXCLUSIONS:

Patients who use hospice services any time during the measurement period: G9702

OR

Children who are taking antibiotics in the 30 days prior to the diagnosis of pharyngitis: G9703

Table 1 – Antibiotic Medications

Description Prescription
Aminopenicillins Amoxicillin

Ampicillin

Beta-lactamase inhibitors Ampicillin clavulanate
First generation cephalosporins Cefadroxil

Cephalexin

Cefazolin

Folate antagonist Trimethoprim
Lincomycin derivatives Clindamycin
Macrolides Azithromycin

Erythromycin ethylsuccinate

Clarithromycin

Erythromycin lactobionate

Erythromycin

Erythromycin stearate

Miscellaneous antibiotics Erythromycin-sulfisoxazole
Natural penicillins Penicillin G potassium

Penicillin V potassium

Penicillin G sodium

Penicillinase-resistant penicillins Dicloxacillin
Quinolones Ciprofloxacin

Moxifloxacin

Levofloxacin

Ofloxacin

Second generation cephalosporins Cefaclor

Cefuroxime

Cefprozil

Sulfonamides Sulfamethoxazole-trimethoprim
Tetracyclines Doxycycline

Tetracycline

Minocycline

Third generation cephalosporins Cefdinir

Ceftibuten

Cefixime

Cefditoren

Cefpodoxime

Ceftriaxone

Numerator

Children with a group A streptococcus test in the 7-day period from 3 days prior through 3 days after the diagnosis of pharyngitis

Numerator Instructions:

A higher score indicates appropriate treatment of children with pharyngitis (e.g., the proportion for whom antibiotics were prescribed with an accompanying step test).

Numerator Options:

Performance Met: Group A Strep Test Performed (3210F)

OR

Performance Not Met: Group A Strep Test not Performed, reason not otherwise specified (3210F with 8P)


Tags

CMS-Emergency-Medicine-2019, CMS-Family-Medicine-2019, CMS-Pediatrics-2019, CMS-Urgent-Care-2019, Emergency Medicine, ENT/Otolaryngology, General Practice/Family Medicine, Hospitalists, Internal Medicine, Pediatrics, Pulmonary Medicine, Quality-2019